GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AYTU
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Aytu Bioscience
(Updated on Apr 19, 2024)

Sell candidate since Apr 12, 2024 Loss -3.46% PDF

No changes to the price of Aytu Bioscience stock on the last trading day (Friday, 19th Apr 2024). During the last trading day the stock fluctuated 3.37% from a day low at $2.74 to a day high of $2.83. The price has fallen in 5 of the last 10 days and is down by -13.35% for this period.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.70 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 9.40% during the next 3 months and, with a 90% probability hold a price between $2.95 and $3.72 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AYTU Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 4.10%. Further rise is indicated until a new top pivot has been found. Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Aytu Bioscience stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.86 and $3.02. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Aytu Bioscience stock

Aytu Bioscience finds support from accumulated volume at $2.73 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0923 between high and low, or 3.37%. For the last week, the stock has had daily average volatility of 6.37%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AYTU) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Aytu Bioscience to open at $2.79, and during the day (based on 14 day Average True Range), to move between $2.62 and $2.96, which gives a possible trading interval of +/-$0.172 (+/-6.15%) up or down from last closing price. If Aytu Bioscience takes out the full calculated possible swing range there will be an estimated 12.31% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.73 (2.15%) than the resistance at $2.89 (3.58%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Aytu Bioscience stock A Buy?

The Aytu Bioscience stock holds several negative signals and despite the positive trend, we believe Aytu Bioscience will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.245 Sell Candidate Unchanged

Predicted Opening Price for Aytu Bioscience of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$2.79 ( 0.0848%) $2.79

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AYTU

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.88 3.22 %
R2 2.84 1.96 %
R1 2.82 1.18 %
Current price: 2.79
Support S1 2.75 -1.35 %
S2 2.73 -2.13 %
S3 2.70 -3.39 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.15 12.90 %
R2 2.96 6.09 %
R1 2.89 3.58 %
Current price 2.79
Support S1 2.73 -2.15%
S2 2.68 -3.94%
S3 2.53 -9.32%

FAQ

What is the symbol for Aytu Bioscience Stock and on which exchange is it traded?
The symbol for Aytu Bioscience is AYTU and it is traded on the OTCMKTS (OTC Markets Group).

Should I buy or sell Aytu Bioscience Stock?
The Aytu Bioscience stock holds several negative signals and despite the positive trend, we believe Aytu Bioscience will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Aytu Bioscience Stock?
Aytu Bioscience Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aytu Bioscience Stock.

What's the current price of Aytu Bioscience Stock?
As of the end of day on the 2024-04-19, the price of an Aytu Bioscience (AYTU) share was $2.79.

What is the 52-week high and low for Aytu Bioscience Stock?
The 52-week high for Aytu Bioscience Stock is $3.50 and the 52-week low is $1.38.

What is the market capitalization of Aytu Bioscience Stock?
As of the 2024-04-19, the market capitalization of Aytu Bioscience is 15.534M.

When is the next earnings date for Aytu Bioscience?
The upcoming earnings date for Aytu Bioscience is May 09, 2024.
Click to get the best stock tips daily for free!

About Aytu Bioscience

Aytu Bioscience Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the... AYTU Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT